Aiom: “Adjuvant therapy for breast cancer can change clinical practice”
Saverio Cinieri, president of Aiom at the Asco Congress, 'Adjuvant therapy with ribociclib represents another great ...
Read moreSaverio Cinieri, president of Aiom at the Asco Congress, 'Adjuvant therapy with ribociclib represents another great ...
Read moreSaverio Cinieri, president of Aiom at the Asco Congress: "Adjuvant therapy with ribociclib represents another great ...
Read more"On clinical research, after 13 years, Italy has finally adapted to the European Regulation 536 of ...
Read more© Ruetir 2023. All Rights Reserved.